Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Alternative Payment for Radiation Oncology.

Howard DH, Torres MA.

JAMA. 2019 Oct 9. doi: 10.1001/jama.2019.15888. [Epub ahead of print] No abstract available.

PMID:
31596451
2.

Association Between Self-Reported Hypertension and Antihypertensive Medication Use and Cardiovascular Disease-Related Events and Expenditures Among Patients Diagnosed With Hypertension.

Baker-Goering MM, Howard DH, Will JC, Beeler Asay GR, Roy K.

Public Health Rep. 2019 Sep/Oct;134(5):493-501. doi: 10.1177/0033354919864363. Epub 2019 Aug 12.

PMID:
31404507
3.

Psychiatric Practice Patterns and Barriers to the Adoption of Esketamine.

Wilkinson ST, Howard DH, Busch SH.

JAMA. 2019 Aug 2. doi: 10.1001/jama.2019.10728. [Epub ahead of print] No abstract available.

PMID:
31373610
4.
5.

Physician age and the abandonment of episiotomy.

Howard DH, Hockenberry J.

Health Serv Res. 2019 Jun;54(3):650-657. doi: 10.1111/1475-6773.13132. Epub 2019 Mar 6.

PMID:
30843194
6.

Provider-owned insurers in the individual market.

Howard DH, Herring B, Graves J, Trish E.

Am J Manag Care. 2018 Dec 1;24(12):e393-e398.

7.

Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns.

Liu W, Patil D, Howard DH, Moore RH, Wang H, Sanda MG, Filson CP.

Urol Oncol. 2019 Mar;37(3):181.e15-181.e21. doi: 10.1016/j.urolonc.2018.11.004. Epub 2018 Dec 1.

PMID:
30514604
8.

Evidenced-Based Claims About Evidence.

Howard DH.

MDM Policy Pract. 2017 Oct 12;2(2):2381468317734527. doi: 10.1177/2381468317734527. eCollection 2017 Jul-Dec. No abstract available.

9.

Trends in the Use of Knee Arthroscopy in Adults.

Howard DH.

JAMA Intern Med. 2018 Nov 1;178(11):1557-1558. doi: 10.1001/jamainternmed.2018.4175. No abstract available.

10.

Implementation of Florida Long Term Care Emergency Preparedness Portal Web Site, 2015-2017.

Blake SC, Hawley JN, Henkel AG, Howard DH.

Am J Public Health. 2018 Nov;108(S5):S399-S401. doi: 10.2105/AJPH.2018.304557. Epub 2018 Sep 27.

11.

Mandatory Shared Decision Making by the Centers for Medicare & Medicaid Services for Cardiovascular Procedures and Other Tests.

Merchant FM, Dickert NW Jr, Howard DH.

JAMA. 2018 Aug 21;320(7):641-642. doi: 10.1001/jama.2018.6617. No abstract available.

PMID:
29868828
12.

The Living Donor Lost Wages Trial: Study Rationale and Protocol.

Rodrigue JR, Fleishman A, Carroll M, Evenson AR, Pavlakis M, Mandelbrot DA, Baliga P, Howard DH, Schold JD.

Curr Transplant Rep. 2018 Mar;5(1):45-54. Epub 2018 Jan 19.

13.

Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.

Liu W, Patil D, Howard DH, Moore RH, Wang H, Sanda MG, Filson CP.

Urology. 2018 Jul;117:57-63. doi: 10.1016/j.urology.2018.04.007. Epub 2018 Apr 18.

PMID:
29679601
14.

Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system.

Zhang X, Melanson TA, Plantinga LC, Basu M, Pastan SO, Mohan S, Howard DH, Hockenberry JM, Garber MD, Patzer RE.

Am J Transplant. 2018 Aug;18(8):1936-1946. doi: 10.1111/ajt.14748. Epub 2018 Apr 18.

15.

Physician Reimbursement for Prostate Biopsies Falls as Procedures Shift From Offices to Facilities.

Henry MA, Howard DH, Davies BJ, Filson CP.

Urology. 2018 May;115:96-101. doi: 10.1016/j.urology.2018.02.008. Epub 2018 Mar 12.

PMID:
29545049
16.

Trends in transfusion rates after the FOCUS trial.

Howard DH, Roback JD, Murphy DJ.

J Comp Eff Res. 2018 Feb;7(2):113-120. doi: 10.2217/cer-2017-0038. Epub 2018 Feb 21.

PMID:
29464966
17.

Provider-owned insurers.

Howard DH, Trish E.

Am J Manag Care. 2017 Sep;23(9):566-567. No abstract available.

18.

Cancer-directed therapy and potential impact on survivals in nonresected hepatocellular carcinoma: SEER-Medicare population study.

Kokabi N, Duszak R Jr, Xing M, Howard DH, Applegate KE, Camacho JC, Kim HS.

Future Oncol. 2017 Oct;13(23):2021-2033. doi: 10.2217/fon-2017-0116. Epub 2017 Oct 6. Erratum in: Future Oncol. 2018 Feb;14 (3):307.

PMID:
28984155
19.

The social and economic burden of frontotemporal degeneration.

Galvin JE, Howard DH, Denny SS, Dickinson S, Tatton N.

Neurology. 2017 Nov 14;89(20):2049-2056. doi: 10.1212/WNL.0000000000004614. Epub 2017 Oct 4.

20.

Outcomes and Cost Analysis of Surveillance Strategies After Initial Treatment for Women With Recurrent Ovarian Cancer.

Alexander VM, Gordon AN, Howard DH, Khanna N.

Int J Gynecol Cancer. 2017 Sep;27(7):1333-1342. doi: 10.1097/IGC.0000000000001040.

PMID:
28692633
21.

New Kidney Allocation System Associated With Increased Rates Of Transplants Among Black And Hispanic Patients.

Melanson TA, Hockenberry JM, Plantinga L, Basu M, Pastan S, Mohan S, Howard DH, Patzer RE.

Health Aff (Millwood). 2017 Jun 1;36(6):1078-1085. doi: 10.1377/hlthaff.2016.1625.

22.

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

Sanda MG, Feng Z, Howard DH, Tomlins SA, Sokoll LJ, Chan DW, Regan MM, Groskopf J, Chipman J, Patil DH, Salami SS, Scherr DS, Kagan J, Srivastava S, Thompson IM Jr, Siddiqui J, Fan J, Joon AY, Bantis LE, Rubin MA, Chinnayian AM, Wei JT; and the EDRN-PCA3 Study Group, Bidair M, Kibel A, Lin DW, Lotan Y, Partin A, Taneja S.

JAMA Oncol. 2017 Aug 1;3(8):1085-1093. doi: 10.1001/jamaoncol.2017.0177.

23.

Variation in Use of Prostate Biopsy Following Changes in Prostate Cancer Screening Guidelines.

Henry MA, Howard DH, Davies BJ, Filson CP.

J Urol. 2017 Nov;198(5):1046-1053. doi: 10.1016/j.juro.2017.05.008. Epub 2017 May 6.

PMID:
28487099
24.

Trends in vertebral augmentation for spinal fractures in myeloma patients: a 2002-2012 population-based study using a large national cancer registry.

Chokshi FH, Howard DH, Jarvik JG, Duszak R Jr.

J Neurointerv Surg. 2018 Feb;10(2):183-190. doi: 10.1136/neurintsurg-2017-013011. Epub 2017 Apr 6.

PMID:
28385726
25.

Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation.

Qin X, Tangka FK, Guy GP Jr, Howard DH.

Cancer Causes Control. 2017 Jan;28(1):41-48. doi: 10.1007/s10552-016-0835-1. Epub 2016 Dec 26.

26.

Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.

Rai A, Nastoupil LJ, Williams JN, Lipscomb J, Ward KC, Howard DH, Lee D, Flowers CR.

Leuk Lymphoma. 2017 Jul;58(7):1570-1580. doi: 10.1080/10428194.2016.1253836. Epub 2016 Nov 10.

27.
28.

Absenteeism and Employer Costs Associated With Chronic Diseases and Health Risk Factors in the US Workforce.

Asay GR, Roy K, Lang JE, Payne RL, Howard DH.

Prev Chronic Dis. 2016 Oct 6;13:E141. doi: 10.5888/pcd13.150503.

29.

The accuracy of claims data for measuring transfusion rates.

Howard DH, Karcz A, Roback JD.

Transfus Med. 2016 Dec;26(6):457-459. doi: 10.1111/tme.12358. Epub 2016 Sep 22.

PMID:
27653186
30.

New Anticancer Drugs Associated With Large Increases In Costs And Life Expectancy.

Howard DH, Chernew ME, Abdelgawad T, Smith GL, Sollano J, Grabowski DC.

Health Aff (Millwood). 2016 Sep 1;35(9):1581-7. doi: 10.1377/hlthaff.2016.0286.

PMID:
27605636
31.

Sociodemographic disparities in treatment and survival of small localized renal cell carcinoma: surgical resection versus thermal ablation.

Kokabi N, Xing M, Duszak R Jr, Howard DH, Camacho JC, Kim HS.

J Comp Eff Res. 2016 Aug;5(5):441-52. doi: 10.2217/cer-2016-0014. Epub 2016 Jul 18.

PMID:
27428383
32.

Contrary To Conventional Wisdom, Physicians Abandoned A Breast Cancer Treatment After A Trial Concluded It Was Ineffective.

Howard DH, Soulos PR, Chagpar AB, Mougalian S, Killelea B, Gross CP.

Health Aff (Millwood). 2016 Jul 1;35(7):1309-15. doi: 10.1377/hlthaff.2015.1490.

PMID:
27385249
33.

Association of Antihypertensive Medication Adherence With Healthcare Use and Medicaid Expenditures for Acute Cardiovascular Events.

Yang Z, Howard DH, Will J, Loustalot F, Ritchey M, Roy K.

Med Care. 2016 May;54(5):504-11. doi: 10.1097/MLR.0000000000000515.

PMID:
27078823
34.

Perspectives in Oncology Drug Pricing-Reply.

Goldstein DA, Howard DH, Flowers CR.

JAMA Oncol. 2016 Mar;2(3):402-3. doi: 10.1001/jamaoncol.2015.4997. No abstract available.

PMID:
26967189
35.

Impact of a Sequential Intervention on Albumin Utilization in Critical Care.

Lyu PF, Hockenberry JM, Gaydos LM, Howard DH, Buchman TG, Murphy DJ.

Crit Care Med. 2016 Jul;44(7):1307-13. doi: 10.1097/CCM.0000000000001638.

PMID:
26963324
36.

Sociodemographic impact on survival in unresectable hepatocellular carcinoma: a survival epidemiology and end results study.

Kokabi N, Xing M, Duszak R Jr, Duszak R Jr, Howard DH, Applegate KE, Camacho JC, Kim HS.

Future Oncol. 2016 Jan;12(2):183-98. doi: 10.2217/fon.15.242. Epub 2015 Dec 14. Erratum in: Future Oncol. 2016 Feb;12(4):576. Jr, Richard Duszak [corrected to Duszak, Richard Jr].

PMID:
26690268
37.

Producing Evidence to Reduce Low-Value Care.

Howard DH, Gross CP.

JAMA Intern Med. 2015 Dec;175(12):1893-4. doi: 10.1001/jamainternmed.2015.5453. Review. No abstract available.

PMID:
26457957
38.

Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.

Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ.

Cancer. 2015 Dec 15;121(24):4341-7. doi: 10.1002/cncr.29677. Epub 2015 Sep 15.

39.

Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Ramalingam SS, Khuri FR, Flowers CR.

JAMA Oncol. 2015 Dec;1(9):1293-300. doi: 10.1001/jamaoncol.2015.3316.

PMID:
26313558
40.

Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.

Goldstein DA, Ahmad BB, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR.

J Clin Oncol. 2015 Nov 10;33(32):3727-32. doi: 10.1200/JCO.2015.61.9569. Epub 2015 Aug 24.

41.

Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening.

Goede SL, Kuntz KM, van Ballegooijen M, Knudsen AB, Lansdorp-Vogelaar I, Tangka FK, Howard DH, Chin J, Zauber AG, Seeff LC.

Med Care. 2015 Jul;53(7):630-8. doi: 10.1097/MLR.0000000000000380.

42.

Erratum to: Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012.

Howard DH, Tangka FK, Royalty J, Dalzell LP, Miller J, O'Hara B, Joseph K, Kenney K, Guy G, Hall IJ.

Cancer Causes Control. 2015 May;26(5):669. doi: 10.1007/s10552-015-0591-7. No abstract available.

PMID:
25929887
43.

Erratum to: Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012.

Tangka FK, Howard DH, Royalty J, Dalzell LP, Miller J, O'Hara BJ, Sabatino SA, Joseph K, Kenney K, Guy GP Jr, Hall IJ.

Cancer Causes Control. 2015 May;26(5):687. doi: 10.1007/s10552-015-0584-6. No abstract available.

44.

Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012.

Tangka FK, Howard DH, Royalty J, Dalzell LP, Miller J, O'Hara BJ, Sabatino SA, Joseph K, Kenney K, Guy GP Jr, Hall IJ.

Cancer Causes Control. 2015 May;26(5):671-86. doi: 10.1007/s10552-015-0524-5. Epub 2015 Mar 18. Erratum in: Cancer Causes Control. 2015 May;26(5):687.

45.

Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012.

Howard DH, Tangka FK, Royalty J, Dalzell LP, Miller J, O'Hara B, Joseph K, Kenney K, Guy G, Hall IJ.

Cancer Causes Control. 2015 May;26(5):657-68. doi: 10.1007/s10552-015-0553-0. Epub 2015 Mar 17. Erratum in: Cancer Causes Control. 2015 May;26(5):669.

46.

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR.

J Clin Oncol. 2015 Apr 1;33(10):1112-8. doi: 10.1200/JCO.2014.58.4904. Epub 2015 Feb 17.

47.

Influenza vaccination rates and beliefs about vaccination among nursing home employees.

Daugherty JD, Blake SC, Grosholz JM, Omer SB, Polivka-West L, Howard DH.

Am J Infect Control. 2015 Feb;43(2):100-6. doi: 10.1016/j.ajic.2014.08.021.

PMID:
25637113
48.

Pricing in the Market for Anticancer Drugs.

Howard DH, Bach PB, Berndt ER, Conti RM.

J Econ Perspect. 2015;29(1):139-62. No abstract available.

PMID:
28441702
49.

Accuracy of influenza vaccination rate estimates in United States nursing home residents.

Grosholz JM, Blake S, Daugherty JD, Ayers E, Omer SB, Polivka-West L, Howard DH.

Epidemiol Infect. 2015 Sep;143(12):2588-95. doi: 10.1017/S0950268814003434. Epub 2014 Dec 18.

PMID:
25519437
50.

End-of-Life Medical Costs of Medicaid Cancer Patients.

Tangka FK, Subramanian S, Sabatino SA, Howard DH, Haber S, Hoover S, Richardson LC.

Health Serv Res. 2015 Jun;50(3):690-709. doi: 10.1111/1475-6773.12259. Epub 2014 Nov 25.

Supplemental Content

Loading ...
Support Center